-
Denmark, Australia in the spotlight in Eurovision second semi
-
Heavy Russian strikes on Kyiv kill one, wound 31
-
Xi warns Trump on Taiwan at Beijing summit
-
Iran war and oil dominate BRICS meet in India
-
Bone appetit: Paris pups lap up treats at dog-centric spots
-
Kohli senses end after roaring back to form with IPL century
-
India bars sugar exports until September
-
Madonna, Shakira, BTS to headline first World Cup final half-time show
-
Japan takes 'half step' toward fixing slow retrial system
-
Honda posts operating loss, first since 1957
-
Madonna, Shakira, BTS to headline World Cup final half-time show
-
A quarter of World Cup games risk searing heat: scientists
-
Six hantavirus cruise passengers head to Australia
-
Suspect detained in Philippine senate gunfire: police
-
Cavs top Pistons in overtime for 3-2 series lead
-
Canadian football ready for World Cup coming out party
-
US court suspends sanctions on UN expert on Palestinians
-
Asia markets mixed as Trump-Xi summit, AI trade dominate
-
'Promised to us': The Israelis dreaming of settling south Lebanon
-
'Rare, meaningful': North Korean football team ventures into South
-
In-form Messi hits brace as Miami win 5-3 at Cincinnati in MLS
-
Historic Swiss solar-powered plane crashes into sea
-
A woman UN leader is 'historical justice,' says Ecuadoran contender for top job
-
Indian pharma fuels Africa's 'zombie drug' and opioid crisis
-
After months of blackout, Iran gives internet to select few
-
Wood urges New Zealand to 'create some history' at World Cup
-
In Washington, the fight to preserve Black cemeteries
-
US children's book author sentenced to life after poisoning husband
-
Emotional Vin Diesel leads 'Fast and Furious' tribute in Cannes
-
Battery X Metals Achieves Milestone with Delivery of Next-Generation Patent-Pending Lithium-Ion Battery Rebalancing Machine Featuring Design Enhancements, Advancing Strategic Commercialization Initiatives
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - May 14
-
Akkodis Recognized in HFS Horizons 2026 Report for Enterprise Ready Agentic AI Services
-
Lexus Of Oakville Recognized for Redefining the Luxury Dealership Experience With 2026 Consumer Choice Award
-
US renews offer of $100 mn to Cuba if it cooperates
-
City still 'alive' but need Arsenal slip: Guardiola
-
Man City ease past Palace to keep pressure on Arsenal
-
Alaves end champions Barca's bid for 100-point record
-
US jury begins deliberations on 737 MAX victim suit against Boeing
-
PSG clinch fifth straight Ligue 1 title
-
Inter Milan win Italian Cup to secure domestic double
-
Man City see off Palace to keep pressure on Arsenal
-
Trump and Xi set for high-stakes talks in Beijing
-
S&P 500, Nasdaq end at records as oil prices retreat
-
Iran holds World Cup send-off for national football team
-
McIlroy's toe 'totally fine' after nine-hole PGA practice
-
Rare 'Ocean Dream' blue-green diamond sells for $17 mn at auction
-
California says probing possible violations over World Cup ticket sales
-
US races to secure rare earths to rebuild depleted arsenal
-
Matthew Perry drug middleman jailed for two years
-
Warsh confirmed as Fed chair as central bank faces Trump assault
Climate change, population growth threats as malaria fight stalls
The fight against malaria has stalled after two decades of progress, with climate change and population growth among factors threatening a resurgence of the potentially fatal disease, campaigners said Tuesday.
Insufficient funding for increasingly costly prevention programmes risked efforts against the mosquito-borne illness at a cost of hundreds of thousands of lives and billions of dollars, they said.
The impact would be most keenly felt in Africa which accounts for 95 percent of cases of the disease that claimed 590,000 deaths worldwide in 2023, the African Leaders Malaria Alliance (ALMA) and Malaria No More UK said in a new report.
Several African countries had reported upsurges in cases between January and June 2025 after heavy rainfalls, they said.
Malaria mortality has halved over the past two decades, said the report released ahead of a November 21 meeting in South Africa to secure contributions to the Global Fund to Fight AIDS, TB and Malaria, which covers 59 percent of malaria spending.
"Insufficient funding, however, has caused malaria progress to stall," it said.
"A perfect storm of climate change, rising drug and insecticide resistance, trade disruptions, and global insecurity further undermine the efficacy of malaria interventions."
There were around 263 million cases of malaria globally in 2023, an increase of 11 million cases from the previous year, according to the UN's World Malaria Report 2024.
- Spreading -
"Increases in temperature and flooding due to climate change have increased the number of mosquito breeding sites," ALMA executive secretary Joy Phumaphi told AFP.
In Rwanda, for example, these sites now existed at higher altitudes than previously, she said in an interview.
The malaria-carrying Anopheles stephensi mosquito from Asia has meanwhile spread into Africa while insecticide resistance has increased, she said.
New-generation prevention methods, such as dual-insecticide mosquito nets and the use of drones to disperse chemicals that kill mosquito larva, were effective but also more costly, she said.
At the same time, Africa's population had almost doubled in the past 30 years. "It's more expensive, but we also have to cover a bigger population than before," Phumaphi said.
Malaria -- most prevalent in Nigeria -- is a leading cause of worker and student absenteeism, and also causes learning and cognitive disruption in children.
Besides saving lives, ridding countries of the disease would have "massive" returns on economies, including by boosting productivity and tourism, Phumaphi said.
Malaria "leads to huge amounts of out-of-pocket payments for households and is a major cause of poverty," she said. "Once this market is protected, their purchasing power is enormous."
An anti-malaria vaccine in use in 23 African countries was around 40 percent effective and had to be accompanied by other prevention measures. But a new vaccine undergoing human trials was hoped to show 80 percent efficacy, she said.
Funding modelling showed that a halt in all prevention interventions could cost Africa $83 billion in lost GDP by 2030, alongside 525 million additional cases and 990,000 more deaths on top of the already high annual toll, the report said.
T.Perez--AT